Pharma Innovation Increasingly Viable In Middle-Income Countries
This article was originally published in PharmAsia News
R&D spending grew 455% among PhRMA members in Asia between 2005 and 2010, compared to increases of 112% in Latin America and 303% in India, according to IFPMA survey.
You may also be interested in...
New Approaches To Innovation Needed To Reach Globe's Poor At The "Bottom Of The Pyramid" - And To Fend Off Emerging Competitors Around The World
Regulators in Southeast Asia are working to tighten bribery and corruption enforcement as part of a broader push ahead of an Association of Southeast Asian Nations trade pact in 2015 for greater transparency in pharmaceuticals.